A common use of roxithromycin is to treat chest, tonsil, skin, and genital infections.
Roxithromycin
is an antibiotic that is used to treat infections such as chest, tonsil, skin,
and genital infections. It works by either killing or preventing the growth of
bacteria (bugs). Roxithromycin, like all antibiotics, is ineffective against
viral infections. Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic
macrolide antibiotic that works by interfering with protein synthesis to
prevent bacterial growth. The medication is prescribed to treat bacterial
infections such as pharyngitis, sinusitis, bronchitis, and pneumonia, as well
as urinary and soft tissue infections and otitis media.
Why
isn't roxithromycin available in the United States?
The US Food and Drug Administration has not
approved roxithromycin for marketing in the United States, but it is available
in other countries. Because of the low levels of roxithromycin in breastmilk,
it is unlikely to cause side effects in breastfed infants.
Is
roxithromycin equivalent to amoxicillin?
Amoxicillin and roxithromycin are both equally
effective in the treatment of patients with lower respiratory tract infections
who require antibiotics. After 10 days of treatment with either drug, the
majority of patients are still symptomatic.
Roxithromycin
Medical Valley is approved to treat Mycoplasma pneumoniae, Chlamydia psittaci
(hornitos), and Chlamydia pneumoniae pneumonia (TW AR). Pharyngotonicillitis.
Otitis media with effusion. Pneumonia is acquired socially. Infections of the skin
and soft tissues (see SmPC for the full indication). It is administered orally
and contains the active ingredient roxithromycin.
Important
Roxithromycin Medical Valley risks are those that necessitate special risk
management activities to further investigate or mitigate the risk, allowing the
medicinal product to be taken safely. Significant risks can be classified as
either identified or potential.
Concerns
for which there is sufficient evidence of a link with the use
of Roxithromycin Medical Valley are referred to as identified risks.
Potential risks are concerns about which an association with the use of this
medicine is possible based on available data, but this association has not yet
been established and requires further investigation.
Source-
Comments
Post a Comment